TransUnion (TRU) EVP, CHRO Alicia Zuiker sells 8,673 shares under plan

Rhea-AI Filing Summary

TransUnion executive Alicia Brooke Zuiker, EVP and CHRO, reported a sale of 8,673 shares of Common Stock on August 11, 2026 at $78.49 per share. The transaction is reported as a sale in the open market or a private transaction and was effected pursuant to a Rule 10b5-1 trading plan. After this transaction, Zuiker's directly held position is 41,883 shares of TransUnion common stock.

Insider Trade Summary 10b5-1

Net Seller: 8,673 shares

Net Sell 1 txn

Insider Zuiker Alicia Brooke

Role EVP, CHRO

Sold 8,673 shs ($681K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	8,673	$78.49	$681K

Holdings After Transaction: Common Stock — 41,883 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Key Figures

Shares sold: 8,673 shares Sale price per share: $78.49 per share Shares owned after transaction: 41,883 shares

3 metrics

Shares sold 8,673 shares Common Stock sold on August 11, 2026

Sale price per share $78.49 per share Price for the 8,673 Common Stock shares sold

Shares owned after transaction 41,883 shares Directly held TransUnion Common Stock after the sale

Key Terms

Rule 10b5-1 trading plan, Form 4, Sale in open market or private transaction

3 terms

Rule 10b5-1 trading plan regulatory

"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Sale in open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 05:02 PM Accepted by SEC EDGAR 08/12/2026 - 05:01 PM Learn about SEC filing dates

FAQ

What insider transaction did TransUnion (TRU) report for Alicia Brooke Zuiker?

TransUnion reported that EVP and CHRO Alicia Brooke Zuiker sold 8,673 shares of common stock on August 11, 2026 in an open market or private transaction.

At what price were Alicia Brooke Zuiker’s TransUnion (TRU) shares sold?

The reported sale by Alicia Brooke Zuiker was executed at a price of $78.49 per share, as disclosed for the August 11, 2026 transaction in TransUnion common stock.

How many TransUnion (TRU) shares does Alicia Brooke Zuiker hold after the sale?

Following the August 11, 2026 sale, Alicia Brooke Zuiker directly holds 41,883 shares of TransUnion common stock, as reported in the insider ownership table.

Was the TransUnion (TRU) insider sale under a Rule 10b5-1 plan?

Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan, indicating they followed a pre-established trading arrangement.

What role does Alicia Brooke Zuiker hold at TransUnion (TRU)?

Alicia Brooke Zuiker is identified in the filing as EVP, CHRO of TransUnion, serving as an executive vice president and chief human resources officer.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zuiker Alicia Brooke

(Last) (First) (Middle)

C/O TRANSUNION

555 WEST ADAMS STREET

(Street)

CHICAGO ILLINOIS 60661

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TransUnion [ TRU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHRO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		S(1)		8,673	D	$78.49	41,883	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

Remarks:

	/s/ Rachel Mantz, by power of attorney	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)